Tuesday, March 19, 2013 Monday, March 18, 2013- Dow Starts Another Streak; Problem Is, It's a Losing Oneat Motley Fool (Mon, Mar 18)
- The Demise of a Multibillion-Dollar Drug Class?at Motley Fool (Mon, Mar 18)
- Merck & Co Inc (MRK): Today's Featured Drugs Laggardat TheStreet (Mon, Mar 18)
- Merck to Continue IMPROVE-ITZacks (Mon, Mar 18)
- From Florida to Michigan, small US airports face tower closuresat Reuters (Mon, Mar 18)
- Judge approves $220 million Vioxx settlementat bizjournals.com (Mon, Mar 18)
- There Is Big Money in Drugs.. Legal Ones!at Motley Fool (Mon, Mar 18)
- Cardiome Posts 4Q ProfitZacks (Mon, Mar 18)
- AstraZeneca’s job cuts to save it $190Mat bizjournals.com (Mon, Mar 18)
- Jim Cramer: Buy Merck, Tiffany, and These 3 Solid Stocksat Wall St. Cheat Sheet (Mon, Mar 18)
- Cholesterol Drug Heart Study Continues, But Will Merck's Vytorin Really IMPROVE-IT?at Forbes (Mon, Mar 18)
- Merck's Struggles To Replace Singulair Lead To Biosimilarsat Seeking Alpha (Mon, Mar 18)
- Cervical Cancer Vaccines Spurned by 44% of U.S. Parentsat Bloomberg (Mon, Mar 18)
Sunday, March 17, 2013 Saturday, March 16, 2013 Friday, March 15, 2013Add MRK News to My Yahoo!  | |
|